AQR Capital Management - AKCEA THERAPEUTICS INC ownership

AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 1 filers reported holding AKCEA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of AKCEA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$261,000
-49.5%
14,387
-34.7%
0.00%
-100.0%
Q2 2019$517,000
-25.5%
22,034
-10.1%
0.00%0.0%
Q1 2019$694,000
+5.5%
24,505
+12.2%
0.00%0.0%
Q4 2018$658,00021,8480.00%
Other shareholders
AKCEA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BB BIOTECH AG 2,389,571$61,197,0001.69%
Virtus ETF Advisers LLC 39,351$1,008,0000.88%
Eventide Asset Management 175,000$4,482,0000.21%
ALTRINSIC GLOBAL ADVISORS LLC 187,800$4,810,0000.19%
Bellevue Group AG 48,799$1,250,0000.12%
Perceptive Advisors 97,144$2,488,0000.07%
FMR LLC 10,008,016$256,306,0000.03%
WELLINGTON MANAGEMENT GROUP LLP 3,384,101$86,667,0000.02%
Virtu Financial LLC 12,571$322,0000.02%
Cubist Systematic Strategies, LLC 7,843$201,0000.01%
View complete list of AKCEA THERAPEUTICS INC shareholders